Gene expression profiling in the rat cranial suture Journal Article


Authors: Law, C. S.; Warren, S. M.; Mehrara, B. J.; Ting, K.
Article Title: Gene expression profiling in the rat cranial suture
Abstract: Although many theories have attempted to explain the etiopathogenesis of premature cranial suture fusion, which results in craniosynostosis, recent studies have focused on the role of growth factors and receptors. Using a well-established model of cranial suture biology, the authors developed a novel approach to quantitatively analyze the gene expression profiles of candidate cranial suture growth factors and their receptors. We collected suture mesenchyme and adjacent osteogenic fronts from Sprague-Dawley rats at postnatal days 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 35. RNA was extracted from posterior frontal (PF) and sagittal (SAG) sutures, and reverse transcription-polymerase chain reaction (RT-PCR) was performed for cranial suture candidate cytokines BMP2, BMP3, BMP4, FGF-2, FGFR1, FGFR2, FGFR4, TGF-βRI, TGF-βRII, and TGF-RIII. The authors confirmed quantitative RT-PCR results with Southern and dot blot analyses. Suture growth factor and receptor expression levels changed significantly with time. Expression levels decreased toward baseline in the SAG suture by day 35. There was a marked difference in FGFR1, FGF-2, TGF-βRI, and TGF-βRII expression levels when comparing the fusing PF and nonfusing SAG sutures. Although FGF-2 ligand expression was low, FGF receptor 1 (FGFR1) levels were markedly elevated with a bimodal expression pattern in both PF and SAG similar to that of BMP2, BMP3, and BMP4. Although there were statistically significant differences in TGF-βRI and TGF-βRII expression in the PF and SAG sutures, TGF-βRIII levels were unchanged. The authors report a novel approach to cranial suture growth factor/receptor profiling and confirm their results with standard analytic tools. The data confirm, quantify, and extend the results of previously published studies. By quantifying the gene expression profiles of normal cranial suture biology, we may begin to understand the aberrant growth factor cascades of craniosynostosis and devise targeted therapeutic interventions that can alter the course of this malady.
Keywords: protein expression; unclassified drug; nonhuman; research design; polymerase chain reaction; animals; animal tissue; reverse transcription polymerase chain reaction; gene expression; gene expression profiling; transforming growth factor beta; fibroblast growth factor 2; rat; immunoblotting; transforming growth factor beta receptor; rats; bone morphogenetic protein 2; nucleic acid hybridization; rats, sprague-dawley; mesoderm; mesenchyme; fibroblast growth factors; fibroblast growth factor receptor 1; fibroblast growth factor receptor 2; rna extraction; bone morphogenetic proteins; receptors, growth factor; southern blotting; bone morphogenetic protein 4; fibroblast growth factor receptor 4; blotting, southern; bone morphogenetic protein (bmp); cranial suture biology; cranial suture mesenchyme-fibroblast growth factor (fgf); growth factors; transforming growth factor (tgf-β); osteogenin; protein transforming growth factor beta receptor 1; protein transforming growth factor beta receptor 2; protein transforming growth factor beta receptor 3; transcription factor saga; cranial suture; craniofacial synostosis; skull development; cranial sutures
Journal Title: Journal of Craniofacial Surgery
Volume: 16
Issue: 3
ISSN: 1049-2275
Publisher: Lippincott Williams & Wilkins  
Date Published: 2005-05-01
Start Page: 378
End Page: 388
Language: English
DOI: 10.1097/01.scs.0000157018.27783.91
PUBMED: 15915100
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 4" - "Export Date: 24 October 2012" - "CODEN: JSURE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Babak Mehrara
    448 Mehrara